Disclosure of the result of Medipal Holdings’ public acquisition of PALTAC. Purchase price is 6,650 yen per share, acquisition period from 2026-05-12 to 2026-07-07, total acquired shares 28,940,739, expected total voting rights after acquisition 92.64%. TOB success, subsequent squeeze-out procedures planned. Delisting is expected.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8283","jir_company_name":"Paltech Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/8283-20260708-01.pdf","jir_short_summary":"Disclosure of the result of Medipal Holdings' public acquisition of PALTAC. Purchase price is 6,650 yen per share, acquisition period from 2026-05-12 to 2026-07-07, total acquired shares 28,940,739, expected total voting rights after acquisition 92.64%. TOB success, subsequent squeeze-out procedures planned. Delisting is expected.","jir_summary":"### Overview\nThis public offering is conducted for Medipal Holdings to acquire PALTAC's ordinary shares, with an acquisition period from May 12, 2026 to July 7, 2026, totaling 41 business days. The purchase price is 6,650 yen per share. The total number of tendered shares is 24,466,104, which exceeds the lower bound of 8,676,100 shares, so all tendered shares will be acquired. After the acquisition, the voting rights are expected to rise to 92.64%.\n\n### Future Policy and Impact\nGoing forward, a squeeze-out procedure is planned to make the tendering shareholders the sole shareholders of the acquirer. Delisting of PALTAC is expected to occur after the procedures under the Tokyo Stock Exchange Prime Market rules are completed. A formal announcement will be made once decisions are reached.","jir_financial_highlights":"Purchase Price: 6,650 \u5186 (Unknown)\nTotal Acquisition Shares: 24,466,104 \u682a (Unknown)\nVoting Rights After Acquisition: 92.64% (Unknown)","jir_category":"","jir_hashtags":"#PALTAC, #TOB, #JapanStocks","jir_key_figures":"Purchase Price: 6,650 yen\nTotal Acquisition Shares: 28,940,739 shares\uff08\u8cb7\u4ed8\u4e88\u5b9a\u6570\u306e\u4e0a\u9650\u306a\u3057\uff0f\u4e0b\u96508,676,100 shares\uff09\nVoting Rights After Acquisition: 92.64%","jir_meta_title":"\u3010PALTAC\u3011 Publication of TOB Result\uff5c2026\u5e747\u67088\u65e5","jir_meta_description":" Reporting the results of Medipal Holdings' public acquisition of PALTAC. Purchase price 6,650 yen, acquisition period 41 business days, voting rights after acquisition 92.64%, future squeeze-out procedures planned.","jir_og_title":"TOB Result for PALTAC\uff5c2026-07-08","jir_og_description":"Reporting the TOB result by Medipal HD for PALTAC. Purchase price 6,650 yen, total acquisition shares 28,940,739, voting rights after acquisition 92.64%, with future procedures and anticipated delisting.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8175,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-77308","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n